Héctor M. García‐García

Author

Also Known As

Dionigi Fischetti, Garcia-Garcia, Hector M., H Garcia-Garcia, H M Garcia-Garcia, H. Garcia-Garcia, H. M. Garcia-Garcia, H. M. Garcia‐Garcia, H.M. Garcia-Garcia, H.M. García-García, Hector Garcia-Garcia

359

Publications

10.2K

Citations

H-Index

Concepts

All Affiliations

Erasmus University Rotterdam Erasmus MC Cardialysis (Netherlands)MedStar Washington Hospital Center Universidade de São Paulo

About

Héctor M. García‐García is an author at Erasmus University Rotterdam specializing in medicine, atherosclerosis, and cardiovascular imaging.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	33	54	3.5K
2	Public Health	19	26	1.4K
3	Engineering	18	22	1.1K
4	Health Sciences	10	10	773
5	Nursing	1	1	54

Héctor M. García‐García

119

Publications

7.7K

Citations

H-Index

Page 1

	Year	Citations
In vivo detection of high-risk coronary plaques by radiofrequency intravascular ultrasound and cardiovascular outcome: results of the ATHEROREMO-IVUS study Jin M. Cheng, Héctor M. García‐García, Sanneke P.M. de Boer, European Heart Journal	2013	365
Safety and performance of the second-generation drug-eluting absorbable metal scaffold in patients with de-novo coronary artery lesions (BIOSOLVE-II): 6 month results of a prospective, multicentre, non-randomised, first-in-man trial Michael Haude, Hüseyin İnce, Alexandre Abizaid, The Lancet Tissue EngineeringPercutaneous Coronary InterventionCardiovascular DiseaseFirst-in-man TrialAtherosclerosis	2015	347
Optical coherence tomography patterns of stent restenosis Nieves Gonzalo, Patrick W. Serruys, Takayuki Okamura, American Heart Journal Vascular ImageHealth SciencesMedical ImagingStent RestenosisBiomedical Imaging	2009	321
Intracoronary Optical Coherence Tomography and Histology at 1 Month and 2, 3, and 4 Years After Implantation of Everolimus-Eluting Bioresorbable Vascular Scaffolds in a Porcine Coronary Artery Model Yoshinobu Onuma, Patrick W. Serruys, Laura Perkins, Circulation	2010	315
Ultrathin, bioresorbable polymer sirolimus-eluting stents versus thin, durable polymer everolimus-eluting stents in patients undergoing coronary revascularisation (BIOFLOW V): a randomised trial David E. Kandzari, Laura Mauri, Jacques Koolen, The Lancet Percutaneous Coronary InterventionCardiovascular DiseaseCoronary RevascularisationRandomised TrialBioflow V	2017	264
Incomplete Stent Apposition and Delayed Tissue Coverage Are More Frequent in Drug-Eluting Stents Implanted During Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction Than in Drug-Eluting Stents Implanted for Stable/Unstable Angina Nieves Gonzalo, Peter Barlis, Patrick W. Serruys, JACC: Cardiovascular Interventions Percutaneous Coronary InterventionThrombosisCardiovascular DiseaseAtherosclerosisCoronary Artery Disease	2009	200
Prospective Assessment of the Diagnostic Accuracy of Instantaneous Wave-Free Ratio to Assess Coronary Stenosis Relevance Javier Escaned, Mauro Echavarría‐Pinto, Héctor M. García‐García, JACC: Cardiovascular Interventions	2015	197
Near-Infrared Spectroscopy Predicts Cardiovascular Outcome in Patients With Coronary Artery Disease Rohit M. Oemrawsingh, Jin M. Cheng, Héctor M. García‐García, Journal of the American College of Cardiology Spectroscopic MethodCardiovascular DiseaseInfrared SensorAtherosclerosisSpectroscopy	2014	193
Sustained safety and performance of the second-generation drug-eluting absorbable metal scaffold in patients with<i>de novo</i>coronary lesions: 12-month clinical results and angiographic findings of the BIOSOLVE-II first-in-man trial Michael Haude, Hüseyin İnce, Alexandre Abizaid, European Heart Journal	2016	183
Fast virtual functional assessment of intermediate coronary lesions using routine angiographic data and blood flow simulation in humans: comparison with pressure wire – fractional flow reserve Michail I. Papafaklis, Takashi Muramatsu, Yuki Ishibashi, EuroIntervention	2014	181

Page 1